FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

40126011000036108: Anzemet (dolasetron mesilate monohydrate 25 mg / 1.25 mL) injection, 1.25 mL ampoule (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2988461000168111 Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule en Synonym Active Case sensitive Australian Medicines Terminology module
3047381000168115 Anzemet (dolasetron mesilate monohydrate 25 mg / 1.25 mL) injection, 1.25 mL ampoule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3088001000168118 Anzemet (dolasetron mesylate monohydrate 25 mg / 1.25 mL) injection, 1.25 mL ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has manufactured dose form injection true Inferred relationship Some
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule Is a trade product unit of use true Inferred relationship Some
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule Is a Anzemet true Inferred relationship Some
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule Is a dolasetron mesilate monohydrate 25 mg/1.25 mL injection, ampoule true Inferred relationship Some
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has manufactured dose form injection solution false Inferred relationship Some
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has unit of use ampoule true Inferred relationship Some 1221413142
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has Australian BoSS dolasetron mesilate monohydrate true Inferred relationship Some 1221413141
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has intended active ingredient dolasetron true Inferred relationship Some 1221413141
Inbound Relationships Type Active Source Characteristic Refinability Group
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has TPUU True Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule Inferred relationship Some 1
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has TPUU True Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start